Literature DB >> 6273910

Two alpha heavy chain disease proteins with different genomic deletions demonstrate that nonexpressed alpha heavy chain genes contain methylated bases.

W Dackowski, S L Morrison.   

Abstract

Two independently arising alpha heavy chain mutants have been found to synthesize heavy chains with CH1 deletions of approximately equal extent. Both were isolated from heavy chain-producing variants of the mouse myeloma W3129 and demonstrate that it is possible to arrive at the heavy chain disease phenotype by the pathway H + L leads to H leads to delta H. Analysis of genomic DNA by digestion with restriction endonucleases followed by molecular hybridization showed that one mutant (delta 37) had a deletion of approximately 0.2 kilobase and the second mutant (delta 15) had a deletion of approximately 0.5 kilobase. Mouse myeloma cells contain several alpha chain alleles but only one is expressed; the presence of the deletion in delta 37 and delta 15 made it possible to identify the restriction fragments from the expressed allele. Analysis of the fragments produced after cleavage with an isoschizomeric pair of restriction enzymes, Msp I and Hpa II, indicated that, in the W3129 cell line and its variants, the unexpressed alpha alleles contain methylated bases. The influence of methylation on gene expression remains to be elucidated.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6273910      PMCID: PMC349201          DOI: 10.1073/pnas.78.11.7091

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  36 in total

1.  Rapid isolation of antigens from cells with a staphylococcal protein A-antibody adsorbent: parameters of the interaction of antibody-antigen complexes with protein A.

Authors:  S W Kessler
Journal:  J Immunol       Date:  1975-12       Impact factor: 5.422

2.  A complete immunoglobulin gene is created by somatic recombination.

Authors:  C Brack; M Hirama; R Lenhard-Schuller; S Tonegawa
Journal:  Cell       Date:  1978-09       Impact factor: 41.582

3.  Intragenic DNA spacers interrupt the ovalbumin gene.

Authors:  R Weinstock; R Sweet; M Weiss; H Cedar; R Axel
Journal:  Proc Natl Acad Sci U S A       Date:  1978-03       Impact factor: 11.205

Review 4.  Structural variants of human and murine immunoglobulins.

Authors:  E C Franklin; B Frangione
Journal:  Contemp Top Mol Immunol       Date:  1975

Review 5.  Molecular analysis of spontaneous somatic mutants.

Authors:  K Adetugbo; C Milstein; D S Secher
Journal:  Nature       Date:  1977-01-27       Impact factor: 49.962

6.  Cloning of mouse myeloma cells and detection of rare variants.

Authors:  P Coffino; R Baumal; R Laskov; M D Scharff
Journal:  J Cell Physiol       Date:  1972-06       Impact factor: 6.384

7.  Spontaneous somatic frameshift mutation in a mouse myeloma.

Authors:  K Adetugbo; C Milstein
Journal:  J Mol Biol       Date:  1978-05-15       Impact factor: 5.469

8.  Murine heavy chain disease.

Authors:  S L Morrison
Journal:  Eur J Immunol       Date:  1978-03       Impact factor: 5.532

9.  Resolution of multiple ribonucleic acid species by polyacrylamide gel electrophoresis.

Authors:  A C Peacock; C W Dingman
Journal:  Biochemistry       Date:  1967-06       Impact factor: 3.162

10.  Activity of multiple light chain genes in murine myeloma cells producing a single, functional light chain.

Authors:  F W Alt; V Enea; A L Bothwell; D Baltimore
Journal:  Cell       Date:  1980-08       Impact factor: 41.582

View more
  10 in total

1.  A DNA insertion/deletion necessitates an aberrant RNA splice accounting for a mu heavy chain disease protein.

Authors:  A Bakhshi; P Guglielmi; U Siebenlist; J V Ravetch; J P Jensen; S J Korsmeyer
Journal:  Proc Natl Acad Sci U S A       Date:  1986-04       Impact factor: 11.205

2.  Isolation and characterization of a variant of mouse plasmacytoma J558 synthesizing a 110,000-dalton immunoglobulin heavy chain and of secondary variants synthesizing either a 55,000-dalton or an 80,000-dalton immunoglobulin heavy chain: possible implications.

Authors:  L Matsuuchi; S L Morrison
Journal:  Mol Cell Biol       Date:  1982-09       Impact factor: 4.272

3.  Myeloma mutant with a novel 3' flanking region: loss of normal sequence and insertion of repetitive elements leads to decreased transcription but normal processing of the alpha heavy-chain gene products.

Authors:  P D Gregor; S L Morrison
Journal:  Mol Cell Biol       Date:  1986-06       Impact factor: 4.272

4.  Loss of type I procollagen gene expression in SV40-transformed human fibroblasts is accompanied by hypermethylation of these genes.

Authors:  M I Parker; K Judge; W Gevers
Journal:  Nucleic Acids Res       Date:  1982-10-11       Impact factor: 16.971

5.  Loss of a consensus splice signal in a mutant immunoglobulin gene eliminates the CH1 domain exon from the mRNA.

Authors:  C R Brandt; S L Morrison; B K Birshtein; C Milcarek
Journal:  Mol Cell Biol       Date:  1984-07       Impact factor: 4.272

6.  Methylation and rearrangement of mouse intracisternal a particle genes in development, aging, and myeloma.

Authors:  L L Mays-Hoopes; A Brown; R C Huang
Journal:  Mol Cell Biol       Date:  1983-08       Impact factor: 4.272

7.  Treatment of human cell lines with 5-azacytidine may result in profound alterations in clonogenicity and growth rate.

Authors:  L Olsson; C Due; M Diamant
Journal:  J Cell Biol       Date:  1985-02       Impact factor: 10.539

8.  Posttranslational association of immunoglobulin heavy chain binding protein with nascent heavy chains in nonsecreting and secreting hybridomas.

Authors:  D G Bole; L M Hendershot; J F Kearney
Journal:  J Cell Biol       Date:  1986-05       Impact factor: 10.539

9.  Assembly and secretion of heavy chains that do not associate posttranslationally with immunoglobulin heavy chain-binding protein.

Authors:  L Hendershot; D Bole; G Köhler; J F Kearney
Journal:  J Cell Biol       Date:  1987-03       Impact factor: 10.539

10.  Immunoglobulin gene expression and DNA methylation in murine pre-B cell lines.

Authors:  S Akira; H Sugiyama; N Sakaguchi; T Kishimoto
Journal:  EMBO J       Date:  1984-03       Impact factor: 11.598

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.